CML
Clinical trials for CML explained in plain language.
Never miss a new study
Get alerted when new CML trials appear
Sign up with your email to follow new studies for CML, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to deepen remission in CML patients
Disease control CompletedThis study tested whether adding the experimental drug asciminib to the standard treatment imatinib helps people with chronic myeloid leukemia (CML) achieve a deeper molecular response (very low cancer levels). It included 104 adults who had been on imatinib for at least a year b…
Matched conditions: CML
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Apr 26, 2026 20:02 UTC
-
Healthy volunteers help calibrate new CML drug
Knowledge-focused CompletedThis study tested a new drug called IkT-001Pro in 64 healthy adults aged 18 to 55. The goal was to see if the body processes it the same way as the standard cancer drug imatinib, and to check for side effects. Participants took single doses of both drugs at different times. This …
Matched conditions: CML
Phase: PHASE1 • Sponsor: Inhibikase Therapeutics • Aim: Knowledge-focused
Last updated May 17, 2026 04:11 UTC